サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1136906

頭蓋内ステントの世界市場-2022-2029

Global Intracranial Stents Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
頭蓋内ステントの世界市場-2022-2029
出版日: 2022年10月13日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場力学

世界の頭蓋内ステント市場は、老年人口の急増、脳動脈瘤や高血圧、コレステロール、糖尿病などの慢性神経疾患の発生率の増加、自己拡張型ステントの分野での技術進歩やステントの柔軟性の改善などにより成長しています。

慢性神経疾患の有病率の上昇が市場の成長を牽引

脳動脈瘤財団（BAF）によると、脳動脈瘤は年間約50万人の死亡の原因となり、女性に多くみられます。BAFは、動脈瘤は35～60歳の年齢層に多く、親、兄弟、子などの一等親に動脈瘤がある場合、その発生が増加すると推定しています。また、結合組織病や多嚢胞性腎臓病などの遺伝性疾患の患者さんは、通常、脳動脈瘤を発症します。

Frontiers in Neurology Journalの2020年9月によると、米国におけるIIHの年間全国発生率は10万人中1.15人でした。また、2020年8月に同誌に発表された別の研究によると、クウェートなどの中東諸国でもIIHの発生率は同程度でしたが、欧米地域よりも高いことがわかりました。10万人あたり2人と推定されました。Journal of Neurology, Neurosurgery and Psychiatry誌によると、中国人は白人よりもICASに対して安全性が低く、発症年齢も早かったと推測されます。ICADの最も進行した段階を表し、一過性脳虚血発作（TIA）や虚血性脳卒中の原因としてよく知られています。

合併症のリスクが市場成長の妨げとなる見込み

頭蓋内ステントメーカーやヘルスケアサービスプロバイダーが直面する厳しい予算上の制約や、ステントの移動に関する合併症や手術後の脳内出血のリスクによる外科医の受け入れの少なさが、予測期間中の市場を抑制するものと思われます。

COVID-19の影響分析

COVID-19の大流行により、選択的手術の減少、サプライチェーンの障害、運用上の課題など、頭蓋内ステント市場に悪影響が生じました。例えば、ストライカーは、売上高が3.6％減少し、純利益は23.2％減少したと報告しました。コビド発生による課題にもかかわらず、同社は2020年11月のライトメディカル社の買収により、開発力、製品・サービスライン、市場のリーチを大幅に強化しました。メドトロニックの神経血管の純売上は、虚血性脳卒中製品の一定の成長と出血性脳卒中製品の緩やかな成長によって牽引されました。出血性脳卒中は、主にPipeline Flex流路転換システムで継続的に成長したが、第4四半期にパンデミックによる手術の中断で減少したことで一部相殺されました。

業界分析

頭蓋内ステントの世界市場は、ポーターのファイブフォース、規制分析、サプライチェーン分析と価格分析、償還政策、技術の進歩、PEST分析などの様々な業界要因に基づいて、市場の詳細な分析を提供します。

世界の頭蓋内ステント市場レポートでは、約45+市場データ表、40+図、180ページの構成で提供しています。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

  • 製品タイプ別市場内訳
  • 疾患別市場内訳
  • デザイン別市場内訳
  • 用途別市場内訳
  • エンドユーザー別市場内訳
  • 地域別市場内訳

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 神経系慢性疾患の増加
    • 抑制要因
      • 合併症のリスク
    • 影響度分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • PEST分析
  • プライシング分析
  • 法規制分析
  • 保険償還分析
  • アンメットニーズ分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、あるいは将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • まとめ

第7章 製品タイプ別

  • 自己拡張型ステント
  • バルーン拡張型ステント
  • ステントアシストコイル塞栓術

第8章 疾患別適応症

  • 脳動脈瘤
  • 頭蓋内狭窄

第9章 デザイン別

  • オープンセル
  • クローズドセル

第10章 用途別

  • ニューロフォーム
  • ソリテール
  • エンタープライズ
  • レオプラス
  • ウィングスパン

第11章 エンドユーザー別

  • 病院
  • 外来手術センター
  • クリニック
  • その他

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第13章 競合情勢

  • 競合シナリオ
  • 市況ポジショニング／シェア分析
  • M&A（合併・買収）分析

第14章 企業プロファイル

  • Medtronic plc
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Penumbra, Inc
  • Stryker Corporation
  • Boston Scientific Corporation Inc
  • Terumo Corporation
  • Cook Medical
  • DePuy Synthes
  • Balt Extrusion S.A
  • MicroPort Scientific Corporation
  • Abbott Laboratories

第15章 頭蓋内ステントの世界市場-DataM

目次
Product Code: DMMD929

Market Overview

The Intracranial Stents Market was valued US$ 360 million in 2021 and is estimated to reach US$ 702.8 million by 2029, growing at a CAGR of 8.98% during the forecast period (2022-2029).

An intracranial stent is a tubular structure that is placed inside the canal, duct, or blood vessel. They are used for the treatment of intracranial stenosis. Intracranial stenosis is caused by narrowing of the blood vessels or blood clots due to the building up of fats, plaque, and other substances in the blood vessels. This condition causes stroke in the carotid artery in the neck or an intracranial artery.

Market Dynamics

The global intracranial stents market is growing due to the rapid rise in the geriatric population, an increase in the incidence of chronic neurological diseases like brain aneurysm and hypertension, cholesterol, and diabetes, and technical advances in the field of self-expanding stents and improvement in flexibility of the stents.

Rising prevalence of chronic neurological diseases drives the growth of the market

According to the Brain Aneurysm Foundation (BAF), a brain aneurysm causes around 500,000 deaths annually and is more common among women. BAF estimates that aneurysms are predominant in the age group of 35-60 years, and their occurrence increases if a first-degree relative like a parent, sibling, or child has aneurysms. In addition, patients with genetic disorders like connective tissue disorders or polycystic kidney disease usually suffer from cerebral aneurysms.

According to September 2020 in Frontiers in Neurology Journal, the annual national incidence for IIH was 1.15 out of 100,000 in the United States. Also, per another study published in August 2020 in the same journal, the incidence of IIH was similar in Middle Eastern countries, such as Kuwait and other regions, but was higher than in western areas. It was estimated at 2 per 100,000. According to the Journal of Neurology, Neurosurgery and Psychiatry, Chinese were more unsafe to ICAS than Caucasians, with an earlier age of onset. It represents the most advanced stage of ICAD and is a common cause of Transient Ischemic Attack (TIA) and ischemic stroke.

Risks of complications are expected to hamper the market growth

Tight budgetary constraints faced by intracranial stents manufacturers and healthcare service providers and fewer acceptances among surgeons due to the risks of complications regarding the stent movement and bleeding in the brain after surgery are going to restrain the market in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic led to a reduced number of elective surgeries, supply chain hurdles, operational challenges, and other adverse impacts on the market for intracranial stents. Stryker, for example, reported a 3.6% decline in sales while net earnings decreased by 23.2%. Despite the challenges posed by the covid outbreak, the company significantly strengthened its development capabilities, product and service lines, and the market reaches through the acquisition of Wright Medical in November 2020. Medtronic's net neurovascular sales were driven by the constant growth of Ischemic stroke products and modest growth in hemorrhagic stroke products. Hemorrhagic stroke saw continuous growth, mainly with the Pipeline Flex flow diversion system, partly offset by a decline in the fourth quarter owing to procedural suspensions caused by the pandemic.

Industry Analysis

The global intracranial stents market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis and pricing analysis, reimbursement policies, technological advancements, PEST analysis.

Segment Analysis

The self-expanding stents segment is expected to hold the largest market share in global intracranial stents market

The self-expanding stents segment accounts for the highest market due to the increasing geriatric population, incidence of intracranial disorders and launch of innovative products will boost segment growth. For instance, in May 2019, Stryker's Neuroform Atlas stent received premarket approval from the U.S. FDA. It comprises a self-expanding stent intended for use with detachable metal embolization coils. In addition, the APOLLO Intracranial Stent System from MicroPort Scientific Corporation is explicitly intended for improving cerebral artery lumen diameter in patients with atherosclerosis in intracranial vessels. This stent system comprises a balloon-expandable stent. Product advancements and initiatives by market players are expected to drive the market for intracranial stents.

Geographical Analysis

North America region holds the largest market share in the global intracranial stents market

North America was held a dominant position in the global intracranial stents market in 2021. High prevalence of neurological diseases coupled with the presence of sophisticated healthcare infrastructure and rising per capita healthcare makes North America the largest revenue generator in the market. According to the Centers for Disease Control and Prevention (CDC), neurological disorders such as epilepsy, Alzheimer's, strokes, multiple sclerosis, and migraines are the 5th leading cause of death in the U.S., affecting around 100 million people every year. This large patient pool costs the nation 800 billion annually, including the cost of health care services, medications, and lost productivity.

This large volume of patients with stroke requires intracranial stenting. As per the American Heart Association, in the year 2020, atherosclerotic stenosis was identified as the primary cause of around 700,000 strokes.

Competitive Landscape

The intracranial stents market is highly competitive, owing to big market players in the industry. The key intracranial stents players which are contributing to the growth of the global market include Penumbra, Inc., Medtronic plc, Stryker Corporation, Boston Scientific Corporation Inc., Terumo Corporation, Cook Medical, DePuy Synthes, Balt Extrusion S.A., MicroPort Scientific Corporation, and Abbott Laboratories among others. The major players are adopting new product development and expansion strategies for global growth in the intracranial stents market. In March 2020, In India, Sree Chitra Tirunal Institute for Medical Sciences and Technology, developed an intracranial flow diverter stent for treating brain aneurysms.

Global Intracranial Stents Market - Key Companies to Watch

Medtronic Plc:

Overview: Medtronic plc is an American company that operates in U.S. and manufactures and markets medical device headquarters in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.

Product Portfolio: Pipeline Flex embolization device is the device indicated for the endovascular treatment of adults (22 years of age or older) with certain wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments.

The global intracranial stents market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Disease Indication
  • 3.3. Market Snippet by Design
  • 3.4. Market Snippet by Uses
  • 3.5. Market Snippet by End-User
  • 3.6. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising prevalence of chronic neurological diseases
    • 4.1.2. Restraint
      • 4.1.2.1. Risks of complications
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. PEST Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Self-expanding stents*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Balloon expanding stents
  • 7.4. Stent-assisted coil embolization

8. By Disease Indication

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication Segment
    • 8.1.2. Market Attractiveness Index, By Disease Indication Segment
  • 8.2. Brain aneurysm*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Intracranial stenosis

9. By Design

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design Segment
    • 9.1.2. Market Attractiveness Index, By Design Segment
  • 9.2. Open-cell
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Closed-cell

10. By Uses

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses Segment
    • 10.1.2. Market Attractiveness Index, By Uses Segment
  • 10.2. Neuroform*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Solitaire
  • 10.4. Enterprise
  • 10.5. Leo Plus
  • 10.6. Wingspan

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 11.1.2. Market Attractiveness Index, By End User Segment
  • 11.2. Hospitals*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Clinics
  • 11.5. Others

12. By Region

  • 12.1. Introduction
  • 12.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 12.3. Market Attractiveness Index, By Region
  • 12.4. North America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. US.
      • 12.4.8.2. Canada
      • 12.4.8.3. Mexico
  • 12.5. Europe
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. Germany
      • 12.5.8.2. U.K.
      • 12.5.8.3. France
      • 12.5.8.4. Italy
      • 12.5.8.5. Spain
      • 12.5.8.6. Rest of Europe
  • 12.6. South America
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.6.8.1. Brazil
      • 12.6.8.2. Argentina
      • 12.6.8.3. Rest of South America
  • 12.7. Asia Pacific
    • 12.7.1. Introduction
    • 12.7.2. Key Region-Specific Dynamics
    • 12.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.7.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.7.8.1. China
      • 12.7.8.2. India
      • 12.7.8.3. Japan
      • 12.7.8.4. Australia
      • 12.7.8.5. Rest of Asia Pacific
  • 12.8. Middle East and Africa
    • 12.8.1. Introduction
    • 12.8.2. Key Region-Specific Dynamics
    • 12.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Medtronic plc
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Penumbra, Inc
  • 14.3. Stryker Corporation
  • 14.4. Boston Scientific Corporation Inc
  • 14.5. Terumo Corporation
  • 14.6. Cook Medical
  • 14.7. DePuy Synthes
  • 14.8. Balt Extrusion S.A
  • 14.9. MicroPort Scientific Corporation
  • 14.10. Abbott Laboratories

LIST NOT EXHAUSTIVE

15. Global Intracranial Stents Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us